
Continuous vs. batch production
While widely adopted in other industries, continuous manufacturing is only just starting to be explored as a production process by…
Changes to the pharmaceutical industry over the last ten years, such as rising price pressures and increasingly complex drugs, have meant that contract service providers have seen an increase in demand for a full-service offering. This is in turn driving consolidation across the CDMO landscape.
Our CEO, Kevin Cook, speaks to Manufacturing Chemist about the current trends impacting the contract manufacturing space and what it takes to succeed as a CDMO in such a competitive marketplace. Read the full roundtable here: http://bit.ly/2ps4O5C.
While widely adopted in other industries, continuous manufacturing is only just starting to be explored as a production process by…
A conversation with Kevin Cook about CDMO-sponsor partnerships and outsourcing Kevin Cook, CEO at Sterling Pharma Solutions recently spoke with…
View our infographic to explore the growth of highly potent molecules and key considerations to unlock their full potential in…
There is a growing demand for hazardous chemistry techniques for synthetic manufacturing processes, propelled by the increasing complexity of new…